Literature DB >> 19737522

The protein kinase IKKepsilon regulates energy balance in obese mice.

Shian-Huey Chiang1, Merlijn Bazuine, Carey N Lumeng, Lynn M Geletka, Jonathan Mowers, Nicole M White, Jing-Tyan Ma, Jie Zhou, Nathan Qi, Dan Westcott, Jennifer B Delproposto, Timothy S Blackwell, Fiona E Yull, Alan R Saltiel.   

Abstract

Obesity is associated with chronic low-grade inflammation that negatively impacts insulin sensitivity. Here, we show that high-fat diet can increase NF-kappaB activation in mice, which leads to a sustained elevation in level of IkappaB kinase epsilon (IKKepsilon) in liver, adipocytes, and adipose tissue macrophages. IKKepsilon knockout mice are protected from high-fat diet-induced obesity, chronic inflammation in liver and fat, hepatic steatosis, and whole-body insulin resistance. These mice show increased energy expenditure and thermogenesis via enhanced expression of the uncoupling protein UCP1. They maintain insulin sensitivity in liver and fat, without activation of the proinflammatory JNK pathway. Gene expression analyses indicate that IKKepsilon knockout reduces expression of inflammatory cytokines, and changes expression of certain regulatory proteins and enzymes involved in glucose and lipid metabolism. Thus, IKKepsilon may represent an attractive therapeutic target for obesity, insulin resistance, diabetes, and other complications associated with these disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737522      PMCID: PMC2756060          DOI: 10.1016/j.cell.2009.06.046

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  53 in total

Review 1.  New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.

Authors:  A R Saltiel
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.

Authors:  D E Moller
Journal:  Trends Endocrinol Metab       Date:  2000-08       Impact factor: 12.015

3.  Adipose tissue cellularity in human obesity.

Authors:  J Hirsch; B Batchelor
Journal:  Clin Endocrinol Metab       Date:  1976-07

4.  High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice.

Authors:  R T Sadikot; E D Jansen; T R Blackwell; O Zoia; F Yull; J W Christman; T S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

5.  Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Authors:  M Yuan; N Konstantopoulos; J Lee; L Hansen; Z W Li; M Karin; S E Shoelson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

6.  Modulation of the JNK pathway in liver affects insulin resistance status.

Authors:  Yoshihisa Nakatani; Hideaki Kaneto; Dan Kawamori; Masahiro Hatazaki; Takeshi Miyatsuka; Taka-Aki Matsuoka; Yoshitaka Kajimoto; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Journal:  J Biol Chem       Date:  2004-08-24       Impact factor: 5.157

7.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis.

Authors:  K R Feingold; W Doerrler; C A Dinarello; W Fiers; C Grunfeld
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.

Authors:  Mathieu Laplante; Henrike Sell; Karen L MacNaul; Denis Richard; Joel P Berger; Yves Deshaies
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

View more
  170 in total

Review 1.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  IL-15Rα is a determinant of muscle fuel utilization, and its loss protects against obesity.

Authors:  Emanuele Loro; Erin L Seifert; Cynthia Moffat; Freddy Romero; Manoj K Mishra; Zheng Sun; Predrag Krajacic; Frederick Anokye-Danso; Ross S Summer; Rexford S Ahima; Tejvir S Khurana
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-12       Impact factor: 3.619

3.  Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε.

Authors:  Christelle Pythoud; W W Shanaka I Rodrigo; Giulia Pasqual; Sylvia Rothenberger; Luis Martínez-Sobrido; Juan Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 4.  Assessment of TANK-binding kinase 1 as a therapeutic target in cancer.

Authors:  Victoria H Cruz; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2017-12-07       Impact factor: 5.782

Review 5.  Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling.

Authors:  Federica Scarano; Micaela Gliozzi; Maria Caterina Zito; Lorenza Guarnieri; Cristina Carresi; Roberta Macrì; Saverio Nucera; Miriam Scicchitano; Francesca Bosco; Stefano Ruga; Anna Rita Coppoletta; Rocco Mollace; Jessica Maiuolo; Irene Bava; Antonio Cardamone; Monica Ragusa; Ernesto Palma; Vincenzo Musolino; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

Review 6.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

7.  Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Andrew V Gomez; Louise Chang; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2018-09-20       Impact factor: 3.641

8.  Increased apoptosis and browning of TAK1-deficient adipocytes protects against obesity.

Authors:  Antonia Sassmann-Schweda; Pratibha Singh; Cong Tang; Astrid Wietelmann; Nina Wettschureck; Stefan Offermanns
Journal:  JCI Insight       Date:  2016-05-19

9.  Structure and ubiquitination-dependent activation of TANK-binding kinase 1.

Authors:  Daqi Tu; Zehua Zhu; Alicia Y Zhou; Cai-hong Yun; Kyung-Eun Lee; Angela V Toms; Yiqun Li; Gavin P Dunn; Edmond Chan; Tran Thai; Shenghong Yang; Scott B Ficarro; Jarrod A Marto; Hyesung Jeon; William C Hahn; David A Barbie; Michael J Eck
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

10.  EBF2 determines and maintains brown adipocyte identity.

Authors:  Sona Rajakumari; Jun Wu; Jeff Ishibashi; Hee-Woong Lim; An-Hoa Giang; Kyoung-Jae Won; Randall R Reed; Patrick Seale
Journal:  Cell Metab       Date:  2013-03-14       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.